+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Anti-Vascular Endothelial Growth Factor Targeting by Curcumin and Thalidomide in Acute Myeloid Leukemia Cells



Anti-Vascular Endothelial Growth Factor Targeting by Curcumin and Thalidomide in Acute Myeloid Leukemia Cells



Asian Pacific Journal of Cancer Prevention 18(11): 3055-3061



Acute myeloid leukemias (AMLs) are blood disorders that exhibit uncontrolled growth and reduction of apoptosis

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 059382043

Download citation: RISBibTeXText

PMID: 29172279


Related references

Growth inhibition and induction of apoptosis in acute myeloid leukemia cells by new indolinone derivatives targeting fibroblast growth factor, platelet-derived growth factor, and vascular endothelial growth factor receptors. Molecular Cancer Therapeutics 5(12): 3105-3112, 2006

Anti-Vascular Endothelial Growth Factor Effects of Sorafenib and Arsenic Trioxide in Acute Myeloid Leukemia Cell Lines. Asian Pacific Journal of Cancer Prevention 18(6): 1655-1661, 2017

Expression of vascular endothelial growth factor in bone marrow cells of patients with acute myeloid leukemia. Di 1 Jun Yi Da Xue Xue Bao 22(4): 357-359, 2002

Significant of Expression of Vascular Endothelial Growth Factor in Acute Myeloid Leukemia and Effect on Harringtonine Induced Apoptosis of HL-60 Cells. Blood 100(11): Abstract No 4502, 2002

Intracellular levels of vascular endothelial growth factor in leukemic cells are an independent predictor of complete remission rate and survival in acute myeloid leukemia. Blood 92(10 Suppl. 1 Part 1-2): 678A, 1998

Effect of thalidomide and arsenic trioxide on the release of tumor necrosis factor-α and vascular endothelial growth factor from the KG-1a human acute myelogenous leukemia cell line. Oncology Letters 1(4): 663-667, 2010

Vascular endothelial growth factor signaling in acute myeloid leukemia. Cellular and Molecular Life Sciences 70(8): 1307-1317, 2013

Vascular endothelial growth factor, a possible paracrine growth factor in human acute myeloid leukemia. Blood 89(6): 1870-1875, 1997

Soluble hepatocyte growth factor (sHGF) and vascular endothelial growth factor (sVEGF) in adult acute myeloid leukemia: relationship to disease characteristics. Hematology 7(5): 273-279, 2002

Down-regulation of cellular vascular endothelial growth factor levels induces differentiation of leukemic cells to functional leukemic-dendritic cells in acute myeloid leukemia. Leukemia and Lymphoma 47(10): 2224-2233, 2006

Lactate dehydrogenase, not vascular endothelial growth factor or basic fibroblast growth factor, positively correlates to bone marrow vascularity in acute myeloid leukemia. Journal of the Chinese Medical Association 69(11): 534-537, 2006

Repression of vascular endothelial growth factor expression by the runt-related transcription factor 1 in acute myeloid leukemia. Cancer Research 71(7): 2761-2771, 2011

Inhibitory Effects of Arsenic Trioxide and Thalidomide on Angiogenesis and Vascular Endothelial Growth Factor Expression in Leukemia Cells. Asian Pacific Journal of Cancer Prevention 19(4): 1127-1134, 2018

Regulation of the acute myeloid leukemia cell line OCI/AML-2 by endothelial nitric oxide synthase under the control of a vascular endothelial growth factor signaling system. Leukemia 15(9): 1433-1441, 2001

Regulation of the acute myeloid leukemia cell line OCI/AML-2 by endothelial nitric oxide synthase under the control of a vascular endothelial growth factor signaling system. Leukemia 15(9): 1433-1441, 2001